Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
latest_posts
- 1
Merz postpones Norway trip for Belgium talks on frozen Russian assets - 2The Way to Business: Startup Illustrations Learned
- 3What's an atmospheric river? AP explains the weather phenomenon
- 4What to know about voluntary chocolate recall
- 5Eating ultra-processed foods could raise precancerous polyp risk for women under 50, according to research
- The Solution to Flexibility: Developing Internal Fortitude Notwithstanding Misfortune
- Moldova says Russian drones violated airspace
- James Webb Space Telescope watches 'Jekyll and Hyde' galaxy shapeshift into a cosmic monster
- Trump administration plan to reduce access to some student loans angers nurses, health care groups
- Mali and Canadian miner Barrick agree to resolve tax dispute, ending 2-year standoff
- Man who grabbed Ariana Grande at 'Wicked: For Good' premiere also rushed Katy Perry onstage this year. Who is he and why is he doing this?
- Flu concerns grow in US as UK sees more cases among kids
- 6 Natural products High In Vitamins,Which One Do You Like to Eat
- The Manual for Electric Vehicles that will be hot dealers in 2023
